Home > Boards > US Listed > Medical - Drugs > Cerus Corporation (CERS)

* * $CERS Video Chart 06-29-2019 * *

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ClayTrader Member Profile
Member Level 
Followed By 8,778
Posts 212,068
Boards Moderated 4
Alias Born 12/27/06
160x600 placeholder
Cerus Corporation Announces FDA PMA Supplement Submission for Pathogen-Reduced Cryoprecipitated Fibrinogen Complex Business Wire - 5/26/2020 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2020 6:23:37 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/5/2020 5:29:53 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/5/2020 4:05:04 PM
Cerus Corporation Announces First Quarter 2020 Results Business Wire - 5/5/2020 4:01:00 PM
Cerus Corporation Announces FDA Approval for INTERCEPT Blood System for Plasma with Alternate Plastic Disposable Kits Business Wire - 5/4/2020 8:30:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/24/2020 12:06:16 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/24/2020 12:02:44 PM
Cerus Corporation to Release First Quarter 2020 Financial Results on May 5, 2020 Business Wire - 4/24/2020 8:30:00 AM
Cerus Corporation Announces Expansion of BARDA Funding to Support Development of INTERCEPT Blood System for Red Blood Cells Business Wire - 4/20/2020 5:50:00 PM
Cerus Corporation Provides Update on COVID-19 Related Activities Business Wire - 4/6/2020 8:30:00 AM
Cerus Corp. Announces the Inclusion of Pathogen Reduction Technology in the ISBT Working Party Recommendations for the Prepar... Business Wire - 4/2/2020 8:30:00 AM
University Hospital Basel, Switzerland Transfuses First Two COVID-19 Patients With INTERCEPT Treated Coronavirus Convalescent... Business Wire - 4/2/2020 8:30:00 AM
Cerus Forms Group to Research Optimal Production of COVID-19 Convalescent Plasma Business Wire - 3/26/2020 8:30:00 AM
Unknown (sec Staff) Edgar (US Regulatory) - 3/24/2020 1:40:08 PM
Unknown (sec Staff) Edgar (US Regulatory) - 3/24/2020 1:39:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/6/2020 6:13:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/2/2020 4:15:15 PM
Cerus Corporation Announces Strategic Organizational Changes Business Wire - 3/2/2020 4:10:00 PM
Cerus Corporation to Participate in Upcoming Investor Conferences Business Wire - 2/25/2020 8:30:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 2/21/2020 4:22:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/20/2020 4:09:21 PM
Cerus Corporation Announces Record Fourth Quarter and Full Year 2019 Financial Results Business Wire - 2/20/2020 4:01:00 PM
U.S. Department of Defense Awards Funding for Study to Evaluate the Use of INTERCEPT Plasma in Traumatic Burn Resuscitation Business Wire - 2/18/2020 8:30:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/14/2020 11:44:16 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist